SCHEMBL8880883

SCHEMBL8880883

COC(=O)/C(=C\c1ccc(C(F)(F)F)cc1)C(C)=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
KDM4E B2RXH2 1/20 0.46
PTGS1 P23219 2/20 0.45
PTGS2 P35354 2/20 0.45
NQO2 P16083 1/20 0.45
HDAC3 O15379 1/20 0.44
ADAM17 P78536 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC10 Q969S8 1/20 0.44
HDAC11 Q96DB2 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
HDAC5 Q9UQL6 1/20 0.44
TDP1 Q9NUW8 2/20 0.44
CYP1A2 P05177 1/20 0.44
GLA P06280 1/20 0.44
POLB P06746 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8880889 1.00 ALDH1A1 (0.46) ALDH1A1KDM4EPTGS1PTGS2NQO2
SCHEMBL8028621 0.87 KDM4E (0.60) ALDH1A1KDM4EPTGS1PTGS2NQO2
SCHEMBL8058606 0.84 PTGS1 (0.47) ALDH1A1PTGS1PTGS2NQO2HDAC3
SCHEMBL8058602 0.84 PTGS1 (0.47) ALDH1A1PTGS1PTGS2NQO2HDAC3
SCHEMBL11552093 0.84 ALDH1A1 (0.42) ALDH1A1KDM4EPTGS1PTGS2NQO2
SCHEMBL11552100 0.84 ALDH1A1 (0.42) ALDH1A1KDM4EPTGS1PTGS2NQO2
SCHEMBL6959846 0.82 GAA (0.47) ALDH1A1KDM4EL3MBTL1GAANPSR1
SCHEMBL6959838 0.82 GAA (0.47) ALDH1A1KDM4EL3MBTL1GAANPSR1
SCHEMBL13539102 0.82 HDAC3 (0.47) PTGS1PTGS2NQO2HDAC3ADAM17
SCHEMBL2572526 0.82 MAPT (0.57) ALDH1A1KDM4ETDP1CYP1A2GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5652251-A 6-amino-1,4-dihydropyridine compounds as medicaments for treatment of the central nervous system, and processes for their preparation BAYER AKTIENGESELLSCHAFT (DE) 1997-07-29 US disclosed
US-5432185-A Treating patients exhibiting acute or chronic ischaemic disorders associated with disorders of microcirculation, without lowering or increasing blood pressure BAYER AKTIENGESELLSCHAFT (DE) 1995-07-11 US disclosed
US-5342847-A Antiischetic agents BAYER AKTIENGESELLSCHAFT (DE) 1994-08-30 US disclosed
US-5234935-A Preventing myocardial infarct BAYER AKTIENGESELLSCHAFT (DE) 1993-08-10 US disclosed